致心律失常性右室心肌病患者猝死的预防:植入型心律转复除颤器还是导管消融?  

Prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy:Implantable cardioverter-defibrillator or catheter ablation?

作　　者：王超 党时鹏 李库林 王如兴 WANG Chao;DANG Shipeng;LI Kulin;WANG Ruxing(Department of Cardiology,Wuxi People's Hospital Affiliated to Nanjing Medical University,Wuxi Jiangsu 214023,China)

机构地区：[1]南京医科大学附属无锡人民医院心内科,江苏无锡214023

出　　处：《实用心电学杂志》2023年第4期261-264,共4页Journal of Practical Electrocardiology

基　　金：无锡市“双百”中青年医疗卫生拔尖人才计划资助项目(BJ2020016)。

摘　　要：致心律失常性右室心肌病(arrhythmogenic right ventricular cardiomyopathy,ARVC)是一种正常心肌被脂肪和(或)纤维组织替代的遗传性心肌病,病变主要局限于右心室,也会累及左心室,临床表现为心力衰竭、室性心动过速及猝死。目前对ARVC的治疗主要包括运动限制、抗心律失常药物、安装植入型心律转复除颤器(implantable cardioverter-defibrillator,ICD)和导管消融。本文主要综述ICD和导管消融在治疗ARVC及预防ARVC患者猝死方面的最新研究进展。Arrhythmogenic right ventricular cardiomyopathy(ARVC)is a kind of genetic cardiomyopathy in which the normal myocardium is replaced by fat and(or)fibrous tissue.The lesion is mainly confined to the right ventricle,and can also involve the left ventricle,with clinical manifestations of heart failure,ventricular tachycardia and sudden death.At present,treatments of ARVC mainly include exercise restrictions,application of antiarrhythmic drugs,implantation of implantable cardioverter-defibrillator(ICD)and catheter ablation.This review mainly summarizes the latest research development of ICD and catheter ablation in the treatment of ARVC and prevention of sudden death in ARVC patients.

关 键 词：致心律失常性右室心肌病 植入型心律转复除颤器 导管消融 室性心动过速 心脏性猝死 

分 类 号：R541.7[医药卫生—心血管疾病] R542.2[医药卫生—内科学]